News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
587,631 Results
Type
Article (47194)
Company Profile (122)
Press Release (540303)
Multimedia
Podcasts (142)
Webinars (19)
Section
Business (156039)
Career Advice (2427)
Deals (29199)
Drug Delivery (141)
Drug Development (71731)
Employer Resources (158)
FDA (16139)
Job Trends (12560)
News (280454)
Policy (30777)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2380)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (134)
Alliances (37133)
ALS (166)
Alzheimer's disease (1728)
Antibody-drug conjugate (ADC) (320)
Approvals (16286)
Artificial intelligence (487)
Autoimmune disease (154)
Automation (32)
Bankruptcy (319)
Best Places to Work (9659)
BIOSECURE Act (23)
Biosimilars (191)
Biotechnology (71)
Bladder cancer (159)
Brain cancer (54)
Breast cancer (598)
Cancer (4596)
Cardiovascular disease (413)
Career advice (2051)
Career pathing (38)
CAR-T (258)
CDC (59)
Celiac Disease (1)
Cell therapy (722)
Cervical cancer (36)
Clinical research (61413)
Collaboration (1485)
Company closure (4)
Compensation (1137)
Complete response letters (72)
COVID-19 (2758)
CRISPR (86)
C-suite (768)
Cystic fibrosis (144)
Data (5867)
Decentralized trials (2)
Denatured (33)
Depression (145)
Diabetes (491)
Diagnostics (5757)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (43)
Drug discovery (215)
Drug pricing (221)
Drug shortages (33)
Duchenne muscular dystrophy (235)
Earnings (69799)
Editorial (65)
Employer branding (20)
Employer resources (141)
Events (96482)
Executive appointments (894)
FDA (19191)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (20)
Funding (1282)
Gene editing (193)
Generative AI (42)
Gene therapy (607)
GLP-1 (1075)
Government (4430)
Grass and pollen (8)
Guidances (379)
Healthcare (15662)
HIV (58)
Huntington's disease (49)
IgA nephropathy (84)
Immunology and inflammation (286)
Immuno-oncology (57)
Indications (94)
Infectious disease (3014)
Inflammatory bowel disease (185)
Inflation Reduction Act (14)
Influenza (106)
Intellectual property (231)
Interviews (454)
IPO (14700)
IRA (57)
Job creations (3214)
Job search strategy (1677)
JPM (66)
Kidney cancer (16)
Labor market (81)
Layoffs (617)
Leadership (39)
Legal (7230)
Liver cancer (91)
Longevity (12)
Lung cancer (614)
Lymphoma (359)
Machine learning (41)
Management (52)
Manufacturing (729)
MASH (166)
Medical device (11949)
Medtech (11993)
Mergers & acquisitions (15495)
Metabolic disorders (1323)
Multiple sclerosis (146)
NASH (22)
Neurodegenerative disease (328)
Neuropsychiatric disorders (96)
Neuroscience (2939)
Neurotech (1)
NextGen: Class of 2026 (5214)
Non-profit (3396)
Now hiring (31)
Obesity (657)
Opinion (281)
Ovarian cancer (152)
Pain (191)
Pancreatic cancer (218)
Parkinson's disease (281)
Partnered (26)
Patents (470)
Patient recruitment (446)
Peanut (54)
People (45670)
Pharmaceutical (35)
Pharmacy benefit managers (32)
Phase 1 (18279)
Phase 2 (26682)
Phase 3 (21677)
Pipeline (4884)
Policy (333)
Postmarket research (2379)
Preclinical (7564)
Press Release (37)
Prostate cancer (242)
Psychedelics (55)
Radiopharmaceuticals (254)
Rare diseases (873)
Real estate (4447)
Recruiting (64)
Regulatory (23571)
Reports (41)
Research institute (2155)
Resumes & cover letters (404)
Rett syndrome (27)
RNA editing (16)
RSV (73)
Schizophrenia (151)
Series A (217)
Series B (172)
Service/supplier (9)
Sickle cell disease (95)
Special edition (25)
Spinal muscular atrophy (143)
Sponsored (46)
Startups (2862)
State (1)
Stomach cancer (20)
Supply chain (104)
Tariffs (101)
The Weekly (108)
Vaccines (1087)
Venture capital (94)
Weight loss (464)
Women's health (72)
Worklife (22)
Date
Today (13)
Last 7 days (558)
Last 30 days (2133)
Last 365 days (28799)
2026 (2733)
2025 (29095)
2024 (32363)
2023 (36360)
2022 (46519)
2021 (50204)
2020 (47190)
2019 (38127)
2018 (28867)
2017 (28813)
2016 (27344)
2015 (30613)
2014 (24111)
2013 (19571)
2012 (21040)
2011 (21511)
2010 (19456)
Location
Africa (697)
Alabama (73)
Alaska (6)
Arizona (240)
Arkansas (10)
Asia (33658)
Australia (5873)
California (10565)
Canada (2615)
China (944)
Colorado (420)
Connecticut (458)
Delaware (304)
Europe (81836)
Florida (1569)
Georgia (324)
Hawaii (4)
Idaho (42)
Illinois (762)
India (51)
Indiana (443)
Iowa (22)
Japan (400)
Kansas (105)
Kentucky (25)
Louisiana (19)
Maine (74)
Maryland (1303)
Massachusetts (7618)
Michigan (274)
Minnesota (569)
Mississippi (5)
Missouri (119)
Montana (12)
Nebraska (22)
Nevada (112)
New Hampshire (62)
New Jersey (2848)
New Mexico (16)
New York (2748)
North Carolina (1370)
North Dakota (7)
Northern California (5213)
Ohio (281)
Oklahoma (15)
Oregon (34)
Pennsylvania (2038)
Puerto Rico (17)
Rhode Island (32)
South America (1057)
South Carolina (63)
South Dakota (1)
Southern California (4118)
Tennessee (153)
Texas (1569)
United States (36989)
Utah (286)
Virginia (245)
Washington D.C. (75)
Washington State (859)
West Virginia (4)
Wisconsin (108)
Wyoming (1)
587,631 Results for "philogen s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 29, 2026
·
2 min read
Press Releases
Indivior Announces Inclusion in the S&P SmallCap 600® Index
December 23, 2025
·
1 min read
Philogen Announces Clinical Trial Collaboration with MSD
Philogen S.p.A. announces that it has entered into a Clinical Trial Collaboration and Supply Agreement with MSD.
June 1, 2023
·
3 min read
Philogen enters into a Service and Supply Agreement with IBSA for the GMP Production of a Therapeutic Protein
Philogen S.p.A announced that it has entered into a Service and Supply Agreement with IBSA to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena.
June 28, 2023
·
4 min read
Press Releases
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 8, 2026
·
3 min read
Business
Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand
Sun Pharmaceutical Industries Limited and Philogen S.p.A announced that they have entered into a licensing agreement for commercializing Philogen’s specialty product, Nidlegy™ in the territories of Europe, Australia and New Zealand.
May 30, 2023
·
5 min read
Press Releases
Bristol Myers Squibb to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 5, 2026
·
1 min read
Press Releases
NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial
January 22, 2026
·
3 min read
Press Releases
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 44th Annual Healthcare Conference
January 6, 2026
·
1 min read
Podcast
JPM26 Recap, Novo’s Oral Wegovy Soars as Lilly’s Orforglipron Is Delayed, IPOs Return
The obesity market and Most Favored Nation drug pricing were among the topics de jour at the J.P. Morgan Healthcare Conference last week, while smaller biotechs sought to assure investors that their regulatory ducks are in a row; Novo Nordisk’s oral obesity pill got off to a hot start while the FDA delayed a decision on Eli Lilly’s investigational offering; and SpyGlass Pharma and AgomAb Therapeutics join the 2026 IPO club.
January 21, 2026
·
1 min read
·
Heather McKenzie
1 of 58,764
Next
